Children to be screened for diabetes risk in UK early detection trial
Study beginning on Monday will assess the risk of type 1 diabetes in 20,000 children aged three to 13Scientists are launching a trial screening programme for type 1 diabetes in the UK to detect the disease earlier and reduce the risk of life-changing complications.About 20,000 children aged between three and 13 are being invited to take part in the Early Surveillance for Autoimmune Diabetes (Elsa) study, with recruitment opening on Monday.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - November 14, 2022 Category: Science Authors: Andrew Gregory Health editor Tags: Diabetes Health UK news Society Science Source Type: news
How the Black Death shaped human evolution
Genetic variants that helped the immune system fight the Black Death may have had the side effect of increasing susceptibility to autoimmune diseases. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - November 8, 2022 Category: Consumer Health News Source Type: news
Selena Gomez Showed A Clip Of An Interviewer Being Rude In Her New Documentary And It ’s Eye-Opening
Well, this week, she dropped her highly anticipated documentary, My Mind & Me.
The film explores how Selena navigates fame and insecurity, all while battling lupus, an autoimmune disease that... #clip #outlet #mymindme #interviewer #hernewdocumentary #documentary #doc #eyeopeningwell #bunch #presstour (Source: Reuters: Health)
Source: Reuters: Health - November 5, 2022 Category: Consumer Health News Source Type: news
Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
RARITAN, N.J., November 3, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson are committed to redefining treatment outcomes in the hematology setting and today announced that abstracts from more than 50 company-sponsored studies, plus more than 20 investigator-initiated studies, will be presented at the American Society of Hematology (ASH) Annual Meeting in New Orleans from December 10-13, 2022. Janssen’s commitment to advancing an innovative portfolio of therapies for healthcare professionals and patients is evidenced through more than 70 presentations that span clinical studies and r...
Source: Johnson and Johnson - November 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
More than $150M designated for new UArizona research center in downtown Phoenix
The center will be focused on cellular and gene-based therapy research connected with the immunology of cancers, autoimmune conditions and infectious diseases. At the center, UArizona is expected to work in close connection with Arizona State University, Northern Arizona University, the Mayo Clinic, the Translational Genomics Research Institute and others in the Bioscience Core. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 2, 2022 Category: Biotechnology Authors: Jeff Gifford Source Type: news
Extrahepatic Autoimmune Diseases in Autoimmune Hepatitis Extrahepatic Autoimmune Diseases in Autoimmune Hepatitis
What is the effect of extrahepatic autoimmune diseases on mortality in patients with autoimmune hepatitis?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 2, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Screening for depressive symptoms in patients with rheumatoid arthritis: relationship with pain severity, disease activity, and sleep quality - Azzam AI, Lamlom M, Khalifa AM.
Rheumatoid arthritis (RA) is an autoimmune systemic condition that primarily affects all synovial joints, eventually leading to deformity and clinical disability. Much progress has been made in the evaluation of inflammation and disease activity in recent ... (Source: SafetyLit)
Source: SafetyLit - November 2, 2022 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news
Autoimmune diseases tied to genes of Black Death survivors, study says
“A hyperactive immune system may have been great” for 14th century plague, “but in the environment today it might not be as helpful,” a researcher said. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - November 1, 2022 Category: Consumer Health News Authors: Jennifer Hassan Source Type: news
With drugs and $120M, Peninsula biotech emerges with focus on immune-mediated diseases
HI-Bio is focusing on autoimmune, allergic, inflammatory and other diseases where immune system players go bad cause diseases. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 1, 2022 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
CAR T Therapy: From Cancer To Autoimmune Disease, The Lupus Example
CAR T cell therapy successfully induced remissions for five lupus patients, according to a recent study. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 1, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
U.S. FDA Approves TECVAYLI ™ (teclistamab-cqyv), the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
HORSHAM, Pa., October 25, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) approved TECVAYLI™ (teclistamab-cqyv) for the treatment of adult patients with relapsed or refractory multiple myeloma, who previously received four or more prior lines of therapy, including a proteasome inhibitor, immunomodulatory drug and anti-CD38 monoclonal antibody.1 TECVAYLI™ is a first-in-class, bispecific T-cell engager antibody that is administered as a subcutaneous treatment.1 This off-the-shelf (or ready to use) therapy uses innovative science to ac...
Source: Johnson and Johnson - October 25, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Amgen completes purchase of ChemoCentryx for $3.7 billion
The deal includes FDA-approved Tavneos, a treatment for a group of autoimmune diseases that cause small vessel inflammation. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 21, 2022 Category: Biotechnology Authors: I-Chun Chen Source Type: news
Chronic Spontaneous Urticaria: What to Know
What you should know about chronic spontaneous urticaria (CSU), including symptoms, triggers, treatment, and a link to autoimmune disease. (Source: WebMD Health)
Source: WebMD Health - October 21, 2022 Category: Consumer Health News Source Type: news
NEJM publishes Tufts' study of skin repigmentation treatment for vitiligo
Vitiligo is a chronic autoimmune disease that causes the skin to lose its natural color. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 20, 2022 Category: American Health Authors: Cassie McGrath Source Type: news
Genetic traits of Black Death survivors linked to autoimmune diseases today
Scientists find people with ERAP2 variant survived 14th-century plague at much higher ratesScientists have identified genetic traits that determined who survived the Black Death more than 700 years ago, but which are today associated with an increased susceptibility to some autoimmune diseases.The study of centuries-old DNA from victims and survivors of the bubonic plague that occurred in the 14th century found that people with what the scientists describe as a “good” variant of a particular gene, known as ERAP2, survived at much higher rates.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - October 19, 2022 Category: Science Authors: Ben Quinn Tags: Health Genetics Society Science Biology Source Type: news
